Citation tools
"Real-world effects of lumacaftor/ivacaftor (LUM/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data." European Respiratory Journal
58.suppl 65
(2021):
PA2098.
Web. 19 April. 2024.